-
Australian Pharmaceutical
Industry: Sector Report
-
Canadian Pharmaceutical Industry:
Sector Report
-
Cannabinoid Market Forecasts &
Analysis to 2012
-
Global Rheumatoid Arthritis Market
Forecasts to 2012
-
GSKs Cervarix - a future
blockbuster of 2007
-
Indian Pharmaceutical Industry:
Sector Report
-
Japanese Pharmaceutical Industry:
Sector Report
-
Late Stage Deals: Strategy,
Structure and Payment Terms
-
Novartis Market Outlook, Forecasts
and Analysis to 2012
-
Pharmaceutical Industry: Key
trends and strategic issues shaping the industry
-
UK Pharmaceutical Industry: Sector
Report
-
US Pharmaceutical Industry: Sector
Report
-
Worldwide Pharmaceutical
Preparation Manufacturing Industry Report 2007
-
Abbott: PharmaVitae Profile 2005
-
Akzo Nobel/Organon: PharmaVitae
Profile
-
Allergan: PharmaVitae Profile 2005
-
Amgen: PharmaVitae Profile 2005
-
Antares Pharma, Inc.:
International Competitive Benchmarks and Financial Gap Analysis
-
Antares Pharma, Inc.: Labor
Productivity Benchmarks and International Gap Analysis
-
Asia Generic Pharmaceuticals
Forecast Report
-
Astellas: PharmaVitae Profile 2005
-
AstraZeneca: PharmaVitae Profile
2005
-
Bayer: PharmaVitae Profile 2005
-
Big Pharma Turns to Biologics for
Growth to 2010: Financial and strategic segmentation of the Big Pharma sector
by drug technology
-
Biogen-IDEC: PharmaVitae Profile
2005
-
Biotechnology Pharmaceuticals -
Private Companies Report - Including Market Size, Market Share and Demand
Forecast
-
Boehringer Ingelheim: PharmaVitae
Profile 2005
-
British Pharmacopoeia 2007
-
China Pharmaceutical Guidebook
Series (3) Material and Clinical Trial Requirements of Application and
Approval for Imported Drug Registration : A Guidebook of Registration
Application for Imported Traditional Chinese Medicines and Natural Medicines
(Multi user license)
-
China Pharmaceutical Guidebook
Series (3) Material and Clinical Trial Requirements of Application and
Approval for Imported Drug Registration : A Guidebook of Registration
Application for Imported Traditional Chinese Medicines and Natural
Medicines(Single User License)
-
China Pharmaceutical Guidebook
Series (4) Material and Clinical Trial Requirements of Application and
Approval for Imported Drug Registration: A Guidebook of Registration
Application for Imported Biological Products (Single User License)
-
China Pharmaceutical Guidebook
Series (4) Material and Clinical Trial Requirements of Application and
Approval for Imported Drug Registration: A Guidebook of Registration
Application for Imported Biological Products(Multi user license)
-
China Pharmaceutical Guidebook
Series(1) Chinese Latest Regulations for Imported Drug Registration:A
Comprehensive Guidebook for Foreign Pharmaceutical Companies (multi user
license)
-
China Pharmaceutical Guidebook
Series(1) Chinese Latest Regulations for Imported Drug Registration:A
Comprehensive Guidebook for Foreign Pharmaceutical Companies(Single User
License)
-
China Pharmaceutical Guidebook
Series(1),(2),(3),(4)(Single User License)
-
China Pharmaceutical Guidebook
Series(1),(2),(3),(4)(Site License)
-
China Pharmaceutical Guidebook
Series(1),(2),(3),(4)(Site License)
-
China Pharmaceutical Guidebook
Series(2) Material and Clinical Trial Requirements of Application and Approval
for Imported Drug Registration: A Guidebook of Registration Application for
Imported Chemical Drugs(Multi user lisence)
-
China Pharmaceutical Guidebook
Series(2) Material and Clinical Trial Requirements of Application and Approval
for Imported Drug Registration: A Guidebook of Registration Application for
Imported Chemical Drugs(Single User license)
-
Company Insight - Penwest
Pharmaceuticals Co
-
Daiichi Sankyo: PharmaVitae
Profile 2005
-
Dainippon Sumitomo Pharma:
PharmaVitae Profile 2005
-
Eisai: PharmaVitae Profile 2005
-
Eli Lilly: PharmaVitae Profile
2005
-
European Pharmaceutical Logistics
Market Map 2005
-
Forest Laboratories: PharmaVitae
Profile
-
Freedonia Focus on Biotechnology:
Pharmaceuticals
-
Freedonia Focus on Ethical
Pharmaceuticals
-
Freedonia Focus on
Over-the-Counter Pharmaceuticals
-
Genentech: PharmaVitae Profile
-
Gilead: PharmaVitae Profile 2005
-
Global OTC Pharmaceuticals
-
Global Pharmaceuticals
-
Global Pharmaceuticals &
Biotechnology
-
Healthcare and Pharmaceutical
Forecasts
-
India Pharmaceuticals & Healthcare
Report
-
India: Pharmaceutical and
Biotechnology Opportunities
-
Indias Growth Prospects in Pharma
: Evolution, Not Revolution
-
Intellectual Property Strategies
for Pharmaceutical Development
-
ITs role in the evolving pharma
industry - Addressing the R&D productivity crisis through new globalization
and convergence strategies
-
Japanese Pharma to 2010 - Imminent
Transition Towards Globalization Necessary for Survival
-
Legal aspects of outsourcing
contracts in the pharmaceutical industry: A practical guide
-
Licensing Agreement in
Pharmaceutical Business Development - 2nd Edition
-
Lundbeck: PharmaVitae Profile 2005
-
Marketing Drugs in an Era of
Pharmacovigilance - Best practice after drug safety scares and the
implications for the future
-
MedImmune: PharmaVitae Profile
-
MedImmune: PharmaVitae Profile
2005
-
Menarini: PharmaVitae Profile 2005
-
Merck & Co: PharmaVitae Profile
2005
-
Merck KGaA: PharmaVitae Profile
2005
-
Mid Pharma Sector: In-licensing
and other externalization strategies
-
Mitsubishi: PharmaVitae Profile
2005
-
Multinational Pharmaceuticals
Companies 2003
-
Novo Nordisk: PharmaVitae Profile
-
Opportunities in Indian Pharma
Sector
-
OTC Pharmaceuticals - Market
Report 2005
-
OTC Pharmaceuticals in
Asia-Pacific
-
OTC Pharmaceuticals in Australia
-
OTC Pharmaceuticals in Belgium
-
OTC Pharmaceuticals in Brazil
-
OTC Pharmaceuticals in Canada
-
OTC Pharmaceuticals in China
-
OTC Pharmaceuticals in Denmark
-
OTC Pharmaceuticals in Europe
-
OTC Pharmaceuticals in France
-
OTC Pharmaceuticals in Germany
-
OTC Pharmaceuticals in Hungary
-
OTC Pharmaceuticals in India
-
OTC Pharmaceuticals in Italy
-
OTC Pharmaceuticals in Japan
-
OTC Pharmaceuticals in Mexico
-
OTC Pharmaceuticals in Norway
-
OTC Pharmaceuticals in Poland
-
OTC Pharmaceuticals in Russia
-
OTC Pharmaceuticals in South
Africa
-
OTC Pharmaceuticals in South Korea
-
OTC Pharmaceuticals in Spain
-
OTC Pharmaceuticals in Sweden
-
OTC Pharmaceuticals in Taiwan
-
OTC Pharmaceuticals in the Czech
Republic
-
OTC Pharmaceuticals in the
Netherlands
-
OTC Pharmaceuticals in the United
Kingdom
-
OTC Pharmaceuticals in the United
States
-
Otsuka Pharmaceutical Co Ltd
Company Profile (OTC Healthcare)
-
Otsuka Pharmaceutical Co Ltd
Company Profile (Soft Drinks)
-
Parallel Trade in Europe and the
US: The challenges facing pharma
-
Partneringdesk Barr
Pharmaceuticals Inc Deals briefing
-
Partneringdesk Daiichi
Pharmaceutical Co Ltd Deals Briefing
-
Partneringdesk Fujisawa
Pharmaceutical Co Ltd Deals Briefing
-
Partneringdesk Mitsubishi Pharma
Corporation Deals Briefing
-
Partneringdesk Ono Pharmaceutical
Co Deals Briefing
-
Partneringdesk Otsuka
Pharmaceutical Co Deals Briefing
-
Partneringdesk Purdue Pharma LP
Deals Briefing
-
Partneringdesk Shire
Pharmaceuticals Group PLC Deals Briefing
-
Partneringdesk Takeda
Pharmaceutical Co Ltd Deals Briefing
-
Partneringdesk Teva Pharmaceutical
Industries Ltd Deals Briefing
-
Partneringdesk UCB Pharma Deals
Briefing
-
Partneringdesk Watson
Pharmaceuticals Inc Deals Briefing
-
Partneringdesk Yamanouchi
Pharmaceutical Co Ltd Deals Briefing
-
Pharmaceutical Business News
-
Pharmaceutical Chemicals - Private
Companies Report - Including Market Size, Market Share and Demand Forecast
-
Pharmaceutical Law Insight
-
Pharmaceutical Outsourcing Part 1:
An Introduction to Contract Manufacturing Strategies - Offshoring is not the
only option to drive productivity and efficiencies
-
Pharmaceutical Outsourcing Part 2:
An Introduction to Drug Discovery Strategies new opportunities lie in a fully
integrated global outsourcing strategy
-
Pharmaceutical Packaging forecasts
to 2010 & 2015
-
Pharmaceutical Sales Forces:
Benchmarking sales force management by geographical market and product
lifecycle
-
Pharmaceuticals & Healthcare
Report
-
Pharmaceuticals & Healthcare
Report Argentina
-
Pharmaceuticals & Healthcare
Report Australia
-
Pharmaceuticals & Healthcare
Report Bahrain
-
Pharmaceuticals & Healthcare
Report Belgium
-
Pharmaceuticals & Healthcare
Report Brazil
-
Pharmaceuticals & Healthcare
Report Bulgaria
-
Pharmaceuticals & Healthcare
Report Chile
-
Pharmaceuticals & Healthcare
Report China
-
Pharmaceuticals & Healthcare
Report Colombia
-
Pharmaceuticals & Healthcare
Report Croatia
-
Pharmaceuticals & Healthcare
Report Czech Republic
-
Pharmaceuticals & Healthcare
Report Egypt
-
Pharmaceuticals & Healthcare
Report Estonia
-
Pharmaceuticals & Healthcare
Report France
-
Pharmaceuticals & Healthcare
Report Germany
-
Pharmaceuticals & Healthcare
Report Greece
-
Pharmaceuticals & Healthcare
Report Hong Kong
-
Pharmaceuticals & Healthcare
Report Hungary
-
Pharmaceuticals & Healthcare
Report Indonesia
-
Pharmaceuticals & Healthcare
Report Iran
-
Pharmaceuticals & Healthcare
Report Israel
-
Pharmaceuticals & Healthcare
Report Italy
-
Pharmaceuticals & Healthcare
Report Japan
-
Pharmaceuticals & Healthcare
Report Jordan
-
Pharmaceuticals & Healthcare
Report Kuwait
-
Pharmaceuticals & Healthcare
Report Latvia
-
Pharmaceuticals & Healthcare
Report Lebanon
-
Pharmaceuticals & Healthcare
Report Lithuania
-
Pharmaceuticals & Healthcare
Report Malaysia
-
Pharmaceuticals & Healthcare
Report Mexico
-
Pharmaceuticals & Healthcare
Report Netherlands
-
Pharmaceuticals & Healthcare
Report Nigeria
-
Pharmaceuticals & Healthcare
Report Oman
-
Pharmaceuticals & Healthcare
Report Pakistan
-
Pharmaceuticals & Healthcare
Report Peru
-
Pharmaceuticals & Healthcare
Report Philippines
-
Pharmaceuticals & Healthcare
Report Poland
-
Pharmaceuticals & Healthcare
Report Puerto Rico
-
Pharmaceuticals & Healthcare
Report Romania
-
Pharmaceuticals & Healthcare
Report Russia
-
Pharmaceuticals & Healthcare
Report Saudi Arabia
-
Pharmaceuticals & Healthcare
Report Serbia & Montenegro
-
Pharmaceuticals & Healthcare
Report Singapore
-
Pharmaceuticals & Healthcare
Report Slovakia
-
Pharmaceuticals & Healthcare
Report Slovenia
-
Pharmaceuticals & Healthcare
Report South Africa
-
Pharmaceuticals & Healthcare
Report South Korea
-
Pharmaceuticals & Healthcare
Report Spain
-
Pharmaceuticals & Healthcare
Report Switzerland
-
Pharmaceuticals & Healthcare
Report Taiwan
-
Pharmaceuticals & Healthcare
Report Thailand
-
Pharmaceuticals & Healthcare
Report Turkey
-
Pharmaceuticals & Healthcare
Report UAE
-
Pharmaceuticals & Healthcare
Report Ukraine
-
Pharmaceuticals & Healthcare
Report United Kingdom
-
Pharmaceuticals & Healthcare
Report Venezuela
-
Pharmaceuticals & Healthcare
Report Vietnam
-
Pharmaceuticals & Healthcare
Report Zimbabwe
-
Pharmaceuticals in Asia-Pacific
-
Pharmaceuticals in Australia
-
Pharmaceuticals in Belgium
-
Pharmaceuticals in Brazil
-
Pharmaceuticals in Canada
-
Pharmaceuticals in China
-
Pharmaceuticals in China to 2010
-
Pharmaceuticals in Czech Republic
-
Pharmaceuticals in Denmark
-
Pharmaceuticals in Europe
-
Pharmaceuticals in France
-
Pharmaceuticals in Germany
-
Pharmaceuticals in Hungary
-
Pharmaceuticals in India
-
Pharmaceuticals in Italy
-
Pharmaceuticals in Japan
-
Pharmaceuticals in Mexico
-
Pharmaceuticals in Norway
-
Pharmaceuticals in Poland
-
Pharmaceuticals in Russia
-
Pharmaceuticals in South Africa
-
Pharmaceuticals in South Korea
-
Pharmaceuticals in Spain
-
Pharmaceuticals in Sweden
-
Pharmaceuticals in Taiwan
-
Pharmaceuticals in the Netherlands
-
Pharmaceuticals in the United
Kingdom
-
Pharmaceuticals in the United
States
-
Pharmaceuticals: Global Industry
Guide
-
Pharmacia Corp : Competitive
Benchmarking Report
-
Pharmacia Corp Company Profile
(OTC Healthcare)
-
Pharmacovigilance: A New Era of
Drug Safety
-
PharmaVitae 2004: Merck KGaA
Global Analysis
-
PharmaVitae 2005: Merger Analysis
Tool
-
PharmaVitae Japanese Comparator
Tool
-
PharmaWatch Health Round-up
-
PharmaWatch: Biotechnology
-
PharmaWatch: Cancer
-
PharmaWatch: Cardiovascular
-
PharmaWatch: CNS
-
PharmaWatch: Immune Disorders &
Inflammation
-
PharmaWatch: Infectious Diseases
-
PharmaWatch: Licensing
-
Pierre Fabre: PharmaVitae Profile
2005
-
Pricing and Reimbursement in the
US: Innovation and robust pharmacoeconomic analysis are key
-
Recordati: PharmaVitae Profile
-
Reissuing pharmaceuticals in the
NHS: Challenging the Chain of Trust
-
RFID in Pharmaceutical Sector
(2005)
-
Roche: PharmaVitae Profile 2005
-
Schwarz: PharmaVitae Profile 2005
-
Scrip Magazine - Pharmaceutical
issues in perspective
-
Serono: PharmaVitae Profile
-
Servier: PharmaVitae Profile 2005
-
Shionogi: PharmaVitae Profile 2005
-
Shire: PharmaVitae Profile
-
Solvay: PharmaVitae Profile 2005
-
Taisho Pharmaceutical Co Ltd
Company Profile (OTC Healthcare)
-
Takeda Pharmaceutical Co Ltd :
Competitive Benchmarking Report
-
Takeda: PharmaVitae Profile 2005
-
Teva Pharmaceutical Industries Ltd
: Competitive Benchmarking Report
-
The Pharmaceutical Industry: Key
events and trends shaping its current status and future direction
-
The Pharmaceuticals Industry
Market Review 2005
-
Toho Pharmaceutical Co Ltd :
Competitive Benchmarking Report
-
UCB: PharmaVitae Profile 2005
-
Web Logs (Blogs) and the
Pharmaceutical Industry
-
West Pharmaceutical Services Inc.:
International Competitive Benchmarks and Financial Gap Analysis
-
West Pharmaceutical Services Inc.:
Labor Productivity Benchmarks and International Gap Analysis
-
World Market for Hygienic or
Pharmaceutical Articles Made of Unhardened Vulcanized Rubber: A 2006 Global
Trade Perspective
-
World Outlook for Ace Inhibitor
Vasodilator Pharmaceuticals 2006-2011
-
World Outlook for Antacid
Pharmaceutical Preparations Excluding Effervescent Salicylate Analgesics
2006-2011
-
World Outlook for Anti-Arrhythmic
Vasodilator Pharmaceuticals 2006-2011
-
World Outlook for Anti-Infective
Pharmaceutical Preparations Affecting Amebacides and Trichomonicides 2006-2011
-
World Outlook for Anti-Infective
Pharmaceutical Preparations Affecting Anthelminics 2006-2011
-
World Outlook for Anti-Neoplastic
Pharmaceutical Agents 2006-2011
-
World Outlook for Anti-Neoplastic
Radioactive Isotopes for Internal Pharmaceutical Use 2006-2011
-
World Outlook for Antibacterial
and Antiseptic Pharmaceuticals 2006-2011
-
World Outlook for Anticoagulant
Pharmaceutical Preparations 2006-2011
-
World Outlook for Antidiarrheal
Pharmaceutical Preparations Excluding Narcotics 2006-2011
-
World Outlook for Antifungal
Pharmaceuticals 2006-2011
-
World Outlook for Antimalarial (plasmodicide)
Pharmaceuticals 2006-2011
-
World Outlook for Antispasmodic
and Anticholinergic Pharmaceutical Preparations Excluding Synthetic and H2
Blocking Agents 2006-2011
-
World Outlook for Antispasmodic
and Antisecretory Pharmaceutical Preparations 2006-2011
-
World Outlook for Antitubercular
Pharmaceuticals Excluding Tuberculostatic Isoniazid (isonicotinic Acid
Hydrazide) Preparations 2006-2011
-
World Outlook for Beta-Receptor
Blocking Agent Hypotensive Pharmaceuticals 2006-2011
-
World Outlook for Bronchial
Dilator and Anti-Asthmatic Pharmaceutical Preparations 2006-2011
-
World Outlook for Calcium Channel
Blocker Vasodilator Pharmaceuticals 2006-2011
-
World Outlook for Cancer Therapy
Pharmaceuticals 2006-2011
-
World Outlook for Coronary
Vasodilator Pharmaceuticals 2006-2011
-
World Outlook for Enema Specialty
Laxative Pharmaceutical Preparations 2006-2011
-
World Outlook for Estrogen
Hormones and Synthetic Substitute Pharmaceuticals 2006-2011
-
World Outlook for Fecal Softener
Laxative Pharmaceutical Preparations 2006-2011
-
World Outlook for Insulins and
Anti-Diabetic Hormones and Synthetic Substitute Pharmaceuticals 2006-2011
-
World Outlook for Irritant
Laxative Pharmaceutical Preparations 2006-2011
-
World Outlook for Local and
Topical Corticoids, Hormones, and Synthetic Hormone Substitute Pharmaceuticals
2006-2011
-
World Outlook for Manufacturing
Pharmaceutical Preparations 2006-2011
-
World Outlook for Opium and
Opium-Derivative Narcotic Internal Analgesic and Antipyretic Pharmaceutical
Preparations 2006-2011
-
World Outlook for Oral
Contraceptive Preparations of Hormones and Synthetic Substitute
Pharmaceuticals 2006-2011
-
World Outlook for Oxytocic
Pharmaceutical Preparations 2006-2011
-
World Outlook for Peripheral
Vasodilator Pharmaceuticals 2006-2011
-
World Outlook for Pharmaceutical
and Medicine Manufacturing 2006-2011
-
World Outlook for Pharmaceutical
Preparations Acting on the Cardiovascular System 2006-2011
-
World Outlook for Pharmaceutical
Preparations Acting on the Digestive or Genito-Urinary Systems 2006-2011
-
World Outlook for Pharmaceutical
Preparations Acting on the Human Cardiovascular System 2006-2011
-
World Outlook for Pharmaceutical
Preparations Acting on the Human Digestive and Genitourinary Systems 2006-2011
-
World Outlook for Pharmaceutical
Preparations Acting on the Respiratory System 2006-2011
-
World Outlook for Pharmaceutical
Preparations Acting on the Skin 2006-2011
-
World Outlook for Pharmaceutical
Preparations Affecting the Central Nervous System and Sense Organs 2006-2011
-
World Outlook for Pharmaceutical
Preparations for Human Use Acting on Skin 2006-2011
-
World Outlook for Pharmaceutical
Preparations for Human Use Acting on the Cardiovascular System 2006-2011
-
World Outlook for Pharmaceutical
Preparations for Human Use Acting on the Central Nervous System and the Sense
Organs 2006-2011
-
World Outlook for Pharmaceutical
Preparations for Human Use Acting on the Digestive or the Genito-Urinary
Systems 2006-2011
-
World Outlook for Pharmaceutical
Preparations for Human Use Acting on the Respiratory System 2006-2011
-
World Outlook for Pharmaceutical
Preparations for Human Use Affecting Neoplasms, the Endocrine System, and
Metabolic Diseases 2006-2011
-
World Outlook for Pharmaceutical
Preparations for Human Use Affecting Parasitic and Ineffective Diseases
Excluding Diagnostics 2006-2011
-
World Outlook for Pharmaceutical
Preparations for Human Use Affecting Parasitic and Infectious Diseases
Excluding Diagnostics 2006-2011
-
World Outlook for Pharmaceutical
Preparations for Veterinary Use 2006-2011
-
World Outlook for Pharmaceutical
Preparations for Veterinary Use Excluding Diagnostics 2006-2011
-
World Outlook for Pharmaceutical
Vitamin, Nutrient, and Hematinic Preparations 2006-2011
-
World Outlook for Pharmaceutical
Vitamin, Nutrient, and Hematinic Preparations for Human Use 2006-2011
-
World Outlook for Pharmaceuticals
Affecting Neoplasms, the Endocrine System, and Metabolic Diseases 2006-2011
-
World Outlook for Pharmacies and
Drug Stores 2006-2011
-
World Outlook for Rauwolfia-Alkaloid
Preparation and Rauwolfia-Diuretic Combination Hypotensive Pharmaceuticals
2006-2011
-
World Outlook for Saline Laxative
Pharmaceutical Preparations 2006-2011
-
World Outlook for Skeletal Muscle
Relaxant Pharmaceutical Preparations 2006-2011
-
World Outlook for Sulfonamide
Pharmaceuticals Excluding Sulfa-Antibiotic Combinations 2006-2011
-
World Outlook for Synthetic
Antispasmodics and Anticholinergics Pharmaceutical Preparations 2006-2011
-
World Outlook for Synthetic
Narcotic Pharmaceutical Preparations 2006-2011
-
World Outlook for Systemic
Antibiotic-Sulfonamide Combination Pharmaceuticals 2006-2011
-
World Outlook for Systemic
Antiviral Pharmaceuticals 2006-2011
-
World Outlook for Systemic
Broad-And Medium-Spectrum Antibiotic Pharmaceutical Preparations of Injectable,
Semisynthetic Single Penicillins 2006-2011
-
World Outlook for Systemic
Broad-And Medium-Spectrum Antibiotic Pharmaceutical Preparations of
Semisynthetic Single Penicillins Excluding Injectable Forms 2006-2011
-
World Outlook for Thyroid and
Anti-Thyroid Preparations of Hormones and Synthetic Substitute Pharmaceuticals
2006-2011
-
World Outlook for Topical
Antibiotic Pharmaceuticals 2006-2011
-
World Outlook for Tuberculostatic
Isoniazid (isonicotinic Acid Hydrazide) Pharmaceuticals 2006-2011
-
World Outlook for Urinary
Antibacterials and Antiseptic Pharmaceutical Preparations 2006-2011
-
World Outlook for Veterinary
Antibiotic Pharmaceuticals Excluding Penicillins and Tetracyclines 2006-2011
-
World Outlook for Veterinary
Pharmaceutical Preparations of Anesthetics 2006-2011
-
World Outlook for Veterinary
Pharmaceutical Preparations of Anthelmintics 2006-2011
-
World Outlook for Veterinary
Pharmaceutical Preparations of Antibiotic Penicillins 2006-2011
-
World Outlook for Veterinary
Pharmaceutical Preparations of Antibiotic Tetracyclines 2006-2011
-
World Outlook for Veterinary
Pharmaceutical Preparations of Antiseptics, Wound Dressings, and Fungicides
2006-2011
-
World Outlook for Veterinary
Pharmaceutical Preparations of External Parasiticides 2006-2011
-
World Outlook for Veterinary
Pharmaceutical Preparations of Hemostatics 2006-2011
-
World Outlook for Veterinary
Pharmaceutical Preparations of Intravenous Solutions and Electrolytes
2006-2011
-
World Outlook for Veterinary
Pharmaceutical Preparations of Sulfonamides 2006-2011
-
World Outlook for Veterinary
Pharmaceutical Preparations of Tranquilizers and Ataractics 2006-2011
-
World Outlook for Veterinary
Pharmaceutical Preparations of Vitamins and Minerals 2006-2011
-
World Outlook for Veterinary
Pharmaceuticals, Medicinal Premixes, and Medicated Pet Care Products Excluding
Diagnostic Preparations and Pet Flea-And-Tick Products 2006-2011
-
World Pharmaceutical Chemicals to
2005 - Market Size, Market Share, Market Leaders, Demand Forecast, Sales,
Company Profiles, Market Research, Industry Trends
-
World Pharmaceutical Packaging II
to 2003 - Market Size, Market Share, Demand Forecast, Sales, Company Profiles,
Market Research, Industry Trends
-
World Pharmaceutical Packaging to
2009 - Market Size, Market Share, Market Leaders, Demand Forecast, Sales,
Company Profiles, Market Research, Industry Trends